These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4235179)

  • 1. [Studies on the quality and quantity of therapeutic (equal frontal, equal external) fibrinolysis in the thrombelastograph].
    Fischbacher W
    Klin Wochenschr; 1968 Sep; 46(18):1000-3. PubMed ID: 4235179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolysis by nicotinic acid derivatives].
    Thies HA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):216-9. PubMed ID: 4106011
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboelastographic study of fibrinolytic agents.
    Summaria L
    Semin Thromb Hemost; 1995; 21 Suppl 4():63-71. PubMed ID: 8747691
    [No Abstract]   [Full Text] [Related]  

  • 4. [On thrombolysis with various thrombolytic agents. I. Studies on experimental human natural blood clots].
    Schmidt HW
    Klin Wochenschr; 1966 Jun; 44(11):618-21. PubMed ID: 4229084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histochemical studies on fibrinolytic activity of experimental thrombi in rats after administration of direct and indirect fibrinolytic agents].
    Denk H; Fischer M
    Thromb Diath Haemorrh; 1970 Oct; 24(1):48-54. PubMed ID: 5483974
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitors of fibrinolysis. A comparative thrombelastographic study.
    Egeblad K
    Scand J Clin Lab Invest Suppl; 1967; 98():1-69. PubMed ID: 4228724
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities of thrombolytic treatment].
    Fischer M
    Wien Klin Wochenschr; 1971 Apr; 83(16):277-82. PubMed ID: 4252066
    [No Abstract]   [Full Text] [Related]  

  • 8. [Leukocytes and fibrinolysis. II. Study of pathological leukocytes].
    Tatarsky I; Sinakos Z; Larrieu MJ; Bernard J
    Nouv Rev Fr Hematol; 1967; 7(1):95-107. PubMed ID: 4226638
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
    [No Abstract]   [Full Text] [Related]  

  • 10. [Observation of plasmin on platelet by means of thrombelastograph].
    Nishi A
    Zasshi Tokyo Ika Daigaku; 1971; 29(1):1-9. PubMed ID: 4261342
    [No Abstract]   [Full Text] [Related]  

  • 11. [Solubility of collagen in fibrinolytic agents].
    Schmitt W; Beneke G
    Klin Wochenschr; 1972 Mar; 50(6):335-7. PubMed ID: 4338646
    [No Abstract]   [Full Text] [Related]  

  • 12. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 13. [Basic principles of thrombolytic therapy].
    van de Loo J
    Internist (Berl); 1969 Jan; 10(1):16-21. PubMed ID: 4190309
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Thrombolytic agents: are suitable methods used for their assessment? Are our investigative efforts directed toward the right goal?
    Von Kaulla KN
    Thromb Res; 1974 Feb; 4(2):367-73. PubMed ID: 4831010
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolytic agents.
    Sherry S
    Dis Mon; 1969 May; ():3-32. PubMed ID: 4241828
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 18. UROKINASE AND NON-ENZYMATIC FIBRINOLYTIC AGENTS.
    MCNICOL GP; DOUGLAS AS
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:34-6. PubMed ID: 14199707
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinolytic and thrombolytic therapy.
    Silver D; Anlyan WG
    J Cardiovasc Surg (Torino); 1965; 5(6):Suppl:190-6. PubMed ID: 4224526
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolytic studies with biguanide derivatives.
    Back N; Wilkens H; Barlow B; Czarnecki J
    Ann N Y Acad Sci; 1968 Mar; 148(3):691-713. PubMed ID: 4968570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.